Cyteir Therapeutics Inc
CYT
Get informed when a big investor buys or sells
+ FollowMarket Cap$108.71M
Close$
$4.15
37.3% upside
Current Fair Value
37.3% upsideUndervalued by 37.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $108.71 Million |
|---|---|
| Enterprise Value | $-20,527,738.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.25 |
| Beta | 0.1 |
| Outstanding Shares | 36,030,474 |
Return
| Return on Equity | -24.70% |
|---|---|
| Return on Assets | -23.57% |
| Return on Invested Capital | -30.73% |
Valuation & Multiples
| P/E Ratio | -2.42 |
|---|---|
| PEG | 3.68 |
| Price to Sales | - |
| Price to Book Ratio | 1.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.53 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Cyteir Therapeutics Inc
31 employees